Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

THIRD CLASS OF DRUGS FOR CERTAIN Rx-TO-OTC SWITCH PRODUCTS

This article was originally published in The Tan Sheet

Executive Summary

THIRD CLASS OF DRUGS FOR CERTAIN Rx-TO-OTC SWITCH PRODUCTS may address some concerns with bringing these products over-the- counter, Public Citizen's Health Research Group Director Sidney Wolfe, MD, suggested at a May 24 forum on Rx-to-OTC switch drugs sponsored by Tufts University's Center for the Study of Drug Development. Wolfe maintained that "for some of the dilemmas that have been posed or will be posed in switching prescription [drugs] over-the-counter, the remedy may well be -- and we've not yet done it once in this country -- the use of a third class of drugs."
Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS082878

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel